3,118
Views
39
CrossRef citations to date
0
Altmetric
Research Article

The public health impact of herbs and nutritional supplements

, &
Pages 761-767 | Received 17 Apr 2009, Accepted 21 Apr 2009, Published online: 22 Jul 2009

References

  • ACS (2007): Dietary Supplements: How To Know What Is Safe. Available at http://www.cancer.org/docroot/ETO/content/ETO_5_3x_How_to_Know_What_Is_Safe_Choosing_and_Using_Dietary_Supplements.asp. Accessed on April 6, 2009.
  • AICR (2007): Food Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC, American Institute for Cancer Research.
  • Blumenthal M, Ferrier GKL, Cavaliere C (2006): Total sales of herbal supplements in United States show steady growth. HerbalGram 71: 64–66.
  • Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999): Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340: 1733–1739.
  • Chu DT, Wong WL, Mavligit GM (1988): Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J Clin Lab Immunol 25: 125–129.
  • CRN (2007): More Consumers Consider Themselves “Regular” Supplement Users, Annual Survey Results Show. Press release. Washington, DC, Council for Responsible Nutrition.
  • Deng G, Cassileth BR (2005): To what extent do cancer patients use complementary and alternative medicine? Nat Clin Pract Oncol 2: 496–497.
  • Deng G, Lin H, Seidman A, Fornier M, D’Andrea G, Wesa K, Yeung S, Cunningham-Rundles S, Vickers AJ, Cassileth B (2009): A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol March 1. [Epub ahead of print]
  • Ferrier GKL, Thwaites LA, Rea PR, Raftery M (2006): US consumer herbal and herbal botanical supplement sales. Nutr Business J [Available at http://www.nutritionbusiness.com ].
  • Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schonthal AH (2009): Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood Feb 3. [Epub ahead of print]
  • Grainger EM, Kim HS, Monk JP, Lemeshow SA, Gong M, Bahnson RR, Clinton SK (2008): Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center. Urol Oncol 26: 125–132.
  • Haller CA, Benowitz NL (2000): Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 343: 1833–1838.
  • Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG (2002): Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 62: 2474–2477.
  • Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG (2008): Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 29: 2162–2168.
  • Kumar NB, Allen K, Bell H. (2005): Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 12: 149–157.
  • Lin H, Cheung SW, Nesin M, Cassileth BR, Cunningham-Rundles S (2007): Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 14: 21–27.
  • Lin H, De Stanchina E, Zhou XK, She Y, Hoang D, Cheung SW, Cassileth B, Cunningham-Rundles S (2009): Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse. Exp Biol Med (Maywood) 234: 342–353.
  • Liu B, Edgerton S, Yang X, Kim A, Ordonez-Ercan D, Mason T, Alvarez K, McKimmey C, Liu N, Thor A (2005): Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res i: 879–886.
  • Lyytinen H, Pukkala E, Ylikorkala O (2009): Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol 113: 65–73.
  • Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E (2005): Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16: 655–663.
  • NMI (2007): Health and Wellness Trends, 8th ed. Harleysville, PA, Natural Marketing Institute.
  • ODS (2009): Dietary Supplements. Available at http://www.ods.od.nih.gov.
  • Powell CB, Dibble SL, Dall’Era JE, Cohen I (2002): Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 12: 214–217.
  • Ragupathi G, Yeung KS, Leung PC, Lee M, Lau CB, Vickers A, Hood C, Deng G, Cheung NK, Cassileth B, Livingston P (2008): Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine 26: 4860–4865.
  • Rock CL (2007): Multivitamin-multimineral supplements: Who uses them? Am J Clin Nutr 85: 277S–279S.
  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002): Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333.
  • Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG (2002): Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol 84: 363–367.
  • USFDA (1995): Dietary Supplement Health and Education Act of 1994. Available at http://www.cfsan.fda.gov/~dms/dietsupp.html. Accessed on April 6, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.